1. Home
  2. ITOS vs OLP Comparison

ITOS vs OLP Comparison

Compare ITOS & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • OLP
  • Stock Information
  • Founded
  • ITOS 2011
  • OLP 1982
  • Country
  • ITOS United States
  • OLP United States
  • Employees
  • ITOS N/A
  • OLP N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • OLP Real Estate Investment Trusts
  • Sector
  • ITOS Health Care
  • OLP Real Estate
  • Exchange
  • ITOS Nasdaq
  • OLP Nasdaq
  • Market Cap
  • ITOS 446.6M
  • OLP 483.3M
  • IPO Year
  • ITOS 2020
  • OLP N/A
  • Fundamental
  • Price
  • ITOS $10.11
  • OLP $22.72
  • Analyst Decision
  • ITOS Hold
  • OLP Strong Buy
  • Analyst Count
  • ITOS 6
  • OLP 1
  • Target Price
  • ITOS $10.40
  • OLP $28.00
  • AVG Volume (30 Days)
  • ITOS 1.6M
  • OLP 56.8K
  • Earning Date
  • ITOS 08-06-2025
  • OLP 08-05-2025
  • Dividend Yield
  • ITOS N/A
  • OLP 7.85%
  • EPS Growth
  • ITOS N/A
  • OLP N/A
  • EPS
  • ITOS N/A
  • OLP 1.29
  • Revenue
  • ITOS N/A
  • OLP $94,839,000.00
  • Revenue This Year
  • ITOS N/A
  • OLP $11.87
  • Revenue Next Year
  • ITOS N/A
  • OLP $4.72
  • P/E Ratio
  • ITOS N/A
  • OLP $17.79
  • Revenue Growth
  • ITOS 177.89
  • OLP 7.07
  • 52 Week Low
  • ITOS $4.80
  • OLP $21.94
  • 52 Week High
  • ITOS $18.13
  • OLP $30.45
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 53.14
  • OLP 43.70
  • Support Level
  • ITOS $10.08
  • OLP $22.41
  • Resistance Level
  • ITOS $10.17
  • OLP $23.42
  • Average True Range (ATR)
  • ITOS 0.04
  • OLP 0.47
  • MACD
  • ITOS -0.02
  • OLP 0.09
  • Stochastic Oscillator
  • ITOS 35.29
  • OLP 52.70

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About OLP One Liberty Properties Inc.

One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.

Share on Social Networks: